Enclomiphene
A daily pill that raises a man's own testosterone while keeping his fertility.
- What it is
- A pill that makes your body raise its own testosterone
- Is it FDA-approved?
- No. The FDA said no in 2016 over study design, not safety
- How strong is the proof?
- Strong: two big human trials
- How you take it
- A pill you swallow once a day
- Typical result
- Higher testosterone in 4 to 6 weeks, sperm kept intact
- Biggest catch
- Any vision change means stop and see an eye doctor
Any word with a dotted underline is a science word — tap it for a plain-English meaning.
In plain words.
Enclomiphene is a daily pill. It is not really a , but it lives in the same low-testosterone toolkit, so we cover it here.
It is a type of drug called a SERM (a medicine that blocks estrogen in some places in the body). By blocking an estrogen signal in the brain, it tricks the brain into telling the body to make more testosterone.
Normal testosterone shots (TRT) add testosterone from outside. That shuts down your own supply and can shrink fertility. Enclomiphene does the opposite. It pushes your own body to make more, so you keep making sperm.
What people use it for.
Men use enclomiphene when their testosterone is low but they still want kids someday. It raises testosterone without killing fertility.
It is also used by men coming off a steroid , to help restart their natural testosterone.
It only works if the problem is in the brain's signal, not the testicles themselves. If your testicles have failed, this will not fix it.
Does it actually work?
Yes, the proof here is strong. This is one of the better-studied options on the site.
A company called Repros ran two big trials (named ZA-301 and ZA-302). They showed enclomiphene raised testosterone while keeping sperm counts up. Regular testosterone shots do the opposite and lower sperm.
The FDA turned it down in 2016. But that was about how the trials were designed, not about safety. Doctors still prescribe it through compounding pharmacies. Testosterone usually rises within 4 to 6 weeks. Sperm changes take 3 to 6 months.
what you’ve probably heard.
The claims floating around online, and how true they actually are.
“Enclomiphene raises your testosterone without wrecking your fertility.”
mostly trueTwo big trials showed it raises testosterone while keeping sperm counts up, the opposite of what plain testosterone shots do. It only works if the low signal starts in the brain, not the testicles.
“The FDA rejected it, so it must be unsafe.”
mythThe 2016 rejection was about how the trials were designed, not about safety. Doctors still prescribe it through compounding pharmacies.
“It's the same thing as Clomid.”
half trueClomid is a related drug, but not the same one. It is a blend of two mirror-image molecules, and enclomiphene is just one of them, taken on its own.
“It's a safe over-the-counter test booster you can just take.”
noIt needs a doctor watching your blood and your eyes. Any vision change, like floaters or flashing lights, means stop and see an eye doctor before restarting.
How you take it.
You take it as a pill, once a day. That is the whole routine.
A common dose is around 12.5 mg a day, but your clinic sets the exact amount and checks your bloodwork.
Give it time. Testosterone moves in about 4 to 6 weeks. If it has not budged by 8 weeks, it is probably not working for you, and it is time to stop.
What to watch out for.
The serious stuff
- Vision changes are the big one. If you get floaters, flashing lights, blurry or shimmery vision, or blind spots, stop the pill and see an eye doctor before restarting. SERMs like this one have caused eye-nerve problems in some people. Do not read past this warning.
- Do not use it if you or your family has had an estrogen-driven cancer or a blood clot problem.
- Do not mix it with testosterone shots. They fight each other, and you get neither effect cleanly.
The common stuff
Some men get a low or irritable mood. It is not common, but it is real. If your mood starts dropping, tell someone and tell your doctor.
If anything feels wrong, talk to a real doctor. We are not your doctor.
Where people get it.
Here are the lanes, safest to riskiest.
- Brand. None. The FDA rejected the brand version in 2016. Note: regular Clomid is a different, related drug, not the same thing.
- . This is the main and safest path, about $50 to $90 a month, through men's-health and TRT clinics. Widely stocked.
- Research-only (). A smaller market, about $30 to $60 a month. Cheaper, but no promise of what is in the vial, and no doctor watching your labs.
- . Basically nonexistent here, because the path is already cheap.
The clinic path is clearly best, because this drug needs blood and eye monitoring.
Our honest take.
Skip it if your testosterone is already normal and you just want a "boost." That is not what this is for, and the risks are not worth it. Also skip the self-bought research version. This drug needs a doctor checking your testosterone, estrogen, blood, eyes, and mood.
If you start, treat it like the real prescription it is. Get the monitoring. Stop at any vision change.
The studies behind this.
We read the research so you don't have to. Here's where the facts on this page come from.
- 01Saffati G, et al. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Translational andrology and urology. 2024;13(9):1984-1990. PMID: 39434750.
- 02Rodriguez KM, et al. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert opinion on pharmacotherapy. 2016;17(11):1561-7. PMID: 27337642.
- 03Thomas J, et al. Efficacy of Clomiphene Citrate Versus Enclomiphene Citrate for Male Infertility Treatment: A Retrospective Study. Cureus. 2023;15(7):e41476. PMID: 37546076.
- 04Hill S, et al. Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men. IDrugs : the investigational drugs journal. 2009;12(2):109-19. PMID: 19204885.
- 05Hohl A, et al. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Archives of endocrinology and metabolism. 2025;69(5). PMID: 41066380.
- 06Earl JA, et al. Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism. Expert review of endocrinology & metabolism. 2019;14(3):157-165. PMID: 31063005.
- 07Franz-Odendaal TA, et al. Clomiphene Citrate and Enclomiphene Hydrochloride Exposure Is Associated With Interfrontal Suture Fusion in Zebrafish. Plastic surgery (Oakville, Ont.). 2023;31(4):383-389. PMID: 37915340.
- 08Kim ED, et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU international. 2016;117(4):677-85. PMID: 26496621.
- 09Schramm RD, et al. Enclomiphene does not alter the postpartum interval of suckled beef cows. Journal of animal science. 1991;69(10):4112-6. PMID: 1778825.
- 10Wiehle RD, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertility and sterility. 2014;102(3):720-7. PMID: 25044085.
- 11Kaminetsky J, et al. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. The journal of sexual medicine. 2013;10(6):1628-35. PMID: 23530575.
- 12Westfahl PK. Enclomiphene induces luteolysis in the nonpregnant guinea pig. Experientia. 1989;45(1):104-6. PMID: 2492231.
- 13Foster J, et al. British Society of Sexual Medicine: Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism. The world journal of men's health. 2026. PMID: 41714894.
- 14Wiehle R, et al. Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. BJU international. 2013;112(8):1188-200. PMID: 23875626.
- 15Kovac JR. Reproductive endocrinology: Oral enclomiphene citrate in obese men with hypogonadism. Nature reviews. Urology. 2016;13(3):133-4. PMID: 26787395.
- 16Ruenitz PC. Rabbit liver microsomal metabolism of enclomiphene. Drug metabolism and disposition: the biological fate of chemicals. 1981;9(5):456-60. PMID: 6117445.
- 17Niederberger C. Re: Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. The Journal of urology. 2015;193(6):2053-4. PMID: 25986825.
- 18Young SL, et al. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertility and sterility. 1999;71(4):639-44. PMID: 10202872.
- 19Opsahl MS, et al. Effects of enclomiphene and zuclomiphene on basal and gonadotrophin-stimulated progesterone secretion by isolated subpopulations of small and large ovine luteal cells. Human reproduction (Oxford, England). 1996;11(6):1250-5. PMID: 8671435.
- 20Tienforti D, et al. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis. Andrology. 2023;11(6):1067-1076. PMID: 36604313.
- 21Huang ES, et al. Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology. 1983;112(2):442-8. PMID: 6401242.
- 22Kaminetsky J, et al. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency. Expert opinion on investigational drugs. 2009;18(12):1947-55. PMID: 19938905.
- 23Helo S, et al. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment. BJU international. 2017;119(1):171-176. PMID: 27511863.
- 24Chang CF, et al. Postpartum interval in beef cows shortened by enclomiphene. Journal of animal science. 1987;65(1):217-23. PMID: 3112086.
- 25Niederberger C. Re: Oral Enclomiphene Citrate Raises Testosterone and Preserves Sperm Counts in Obese Hypogonadal Men, Unlike Topical Testosterone: Restoration Instead of Replacement. The Journal of urology. 2017;197(1):233. PMID: 27979553.
- 26Wang C, et al. Direct inhibitory effect of enclomiphene citrate and estradiol on testis functions in hypophysectomized rats. Biology of reproduction. 1980;22(3):645-53. PMID: 6248140.
- 27Schmidt GE, et al. The effects of enclomiphene and zuclomiphene citrates on mouse embryos fertilized in vitro and in vivo. American journal of obstetrics and gynecology. 1986;154(4):727-36. PMID: 3083679.
- 28Turner RT, et al. Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene. Endocrinology. 1998;139(9):3712-20. PMID: 9724022.
- 29Hohl A, et al. Response to the letter to the editor: Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Archives of endocrinology and metabolism. 2025;69(6):e250547. PMID: 41312855.
- 30Ghobadi C, et al. CYP2D6 is primarily responsible for the metabolism of clomiphene. Drug metabolism and pharmacokinetics. 2008;23(2):101-5. PMID: 18445989.
- 31Marth C, et al. Inhibition of the estradiol-induced growth of cultured human breast cancer cells by the anti-estrogens tamoxifen, desmethyl-tamoxifen, 4-hydroxy-tamoxifen and enclomiphene. Biochemical pharmacology. 1984;33(24):3951-6. PMID: 6439216.
- 32Gregg DW, et al. Effects of enclomiphene on estradiol-induced changes in LH secretion in ewes. Journal of animal science. 1990;68(10):3293-9. PMID: 2123847.
- 33Wilcox JN, et al. Long-term priming with a low dosage of estradiol benzoate or an antiestrogen (enclomiphene) increases nuclear progestin receptor levels in brain. Brain research. 1983;266(2):243-51. PMID: 6409349.
- 34Murphy LC, et al. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. The Journal of clinical endocrinology and metabolism. 1983;57(2):373-9. PMID: 6408114.
- 35Hochu G, et al. Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies. Translational andrology and urology. 2025;14(12):3975-3987. PMID: 41522318.
- 36Achua JK, et al. Leydig stem cells and future therapies for hypogonadism. Current opinion in endocrinology, diabetes, and obesity. 2020;27(6):419-423. PMID: 33003069.
- 37Sasson S, et al. The inhibition of the estrogen receptor's positive cooperative [3H]estradiol binding by the antagonist, clomiphene. The Journal of biological chemistry. 1982;257(19):11540-5. PMID: 7118895.
- 38Joseph T, et al. Are SERMs safe and effective for the treatment of hypogonadism in men?. The Journal of family practice. 2022;71(1):E18-E21. PMID: 35259334.
- 39Kneussl ES, et al. A specific cytosolic estrogen receptor in human term placenta. American journal of obstetrics and gynecology. 1982;144(7):803-9. PMID: 7148904.
- 40Fontenot GK, et al. Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice. BJU international. 2016;117(2):344-50. PMID: 26220499.
- 41Wing LY, et al. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione. Endocrinology. 1988;122(6):2418-27. PMID: 3131115.
- 42Jordan VC, et al. Tamoxifen-stimulated growth of human endometrial carcinoma. Annals of the New York Academy of Sciences. 1991;622:439-46. PMID: 1905895.
- 43Miller GD, et al. Hypothalamic-Pituitary-Testicular Axis Effects and Urinary Detection Following Clomiphene Administration in Males. The Journal of clinical endocrinology and metabolism. 2019;104(3):906-914. PMID: 30295816.
- 44Bayés M, et al. Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology. 2004;26(10):801-27. PMID: 15672123.
- 45Clark JH, et al. Triphenylethylene antiestrogen binding sites (TABS) specificity. Journal of steroid biochemistry. 1987;26(4):433-7. PMID: 3586657.
- 46Bitonti AJ, et al. Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma. Anticancer research. 1996;16(5A):2553-7. PMID: 8917350.
- 47Ross LS. Selective estrogen receptor modulators, male hypogonadism, and infertility. Fertility and sterility. 2014;102(3):687-8. PMID: 25044078.
- 48Bempong DK, et al. Multivariate analysis of capillary electrophoresis separation conditions for Z-E isomers of clomiphene. Journal of pharmaceutical and biomedical analysis. 1996;15(2):233-9. PMID: 8933425.
- 49Trubert J, et al. Comparison between Amorphous States of the Trans/Cis Isomers of Clomiphene: Similarities and Differences. Molecular pharmaceutics. 2025;22(11):6932-6940. PMID: 41071236.
- 50Pakrasi PL, et al. Ovulation induction by antiestrogens in an Indian tropical vespertillionid bat, Scotophilus heathi. Life sciences. 2006;79(23):2217-20. PMID: 16934298.
- 51Nelson EA, et al. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications. Viruses. 2016;8(8). PMID: 27490565.
- 52Olsson JH, et al. Effect of clomiphene isomers on progestin synthesis in cultured human granulosa cells. Human reproduction (Oxford, England). 1987;2(6):463-8. PMID: 3117835.
- 53Olsson JH, et al. Effect of clomiphene isomers on oestradiol synthesis in cultured human granulosa cells. Human reproduction (Oxford, England). 1990;5(8):928-32. PMID: 2081804.
- 54Burghardt RC, et al. Gap junction modulation in rat uterus. II. Effects of antiestrogens on myometrial and serosal cells. Biology of reproduction. 1984;30(1):249-55. PMID: 6421335.
- 55Still JG, et al. Effects of Cis- and trans-clomiphene on the uterine blood flow of oophorectomized ewes. Gynecologic investigation. 1976;7(4):187-200. PMID: 992480.
- 56Teramoto S, et al. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reproductive biomedicine online. 2007;15(2):134-48. PMID: 17697488.
- 57Ross JW, et al. Effects of cis- and trans-clomiphene in the induction of sexual behavior. Endocrinology. 1973;93(3):681-5. PMID: 4721294.
- 58Kronenberg MS, et al. Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium. Endocrinology. 1985;117(4):1480-9. PMID: 2411529.
- 59Bowman SP, et al. Time-related effects of en-clomiphene upon central and peripheral oestrogen target tissues and cytoplasmic receptors. The Journal of endocrinology. 1981;89(1):117-28. PMID: 6783718.
- 60Fritz MA, et al. Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. American journal of obstetrics and gynecology. 1991;165(1):177-85. PMID: 1906682.
Learn about these too.
We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.
Want the rest of the peptide world, in plain English?
New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.